Literature DB >> 1587397

Intracellular defects in glucose metabolism in obese patients with NIDDM.

D E Kelley1, M Mokan, L J Mandarino.   

Abstract

Skeletal muscle insulin resistance in obese patients with non-insulin-dependent diabetes mellitus (NIDDM) is characterized by decreased glucose uptake. Although reduced glycogen synthesis is thought to be the predominant cause for this deficit, studies supporting this notion often have been conducted at supraphysiological insulin concentrations in which glucose storage is the overwhelming pathway of glucose disposal. However, at lower, more physiological insulin concentrations, decreased muscle glucose oxidation could play a significant role. This study was undertaken to determine whether, under euglycemic conditions, insulin resistance for leg muscle glucose uptake in NIDDM patients is due primarily to decreased glucose storage or to oxidation. The leg balance technique and leg indirect calorimetry were used under steady-state euglycemic conditions to estimate muscle glucose uptake, storage, and oxidation in eight moderately obese NIDDM patients and eight matched-control subjects. Leg muscle biopsies also were performed to determine whether alterations in muscle pyruvate dehydrogenase or glycogen synthase activities could explain defects in glucose oxidation or storage. At insulin concentrations of approximately 500-600 pM, leg glucose uptake, oxidation, and storage in the NIDDM group (2.03 +/- 0.42, 1.00 +/- 0.13, 0.66 +/- 0.36 mumol.min-1.100 ml-1) were significantly lower (P less than 0.05) than rates in control subjects (5.14 +/- 0.64, 1.92 +/- 0.17, 2.80 +/- 0.54). Pyruvate dehydrogenase and glycogen synthase activities were also decreased, consistent with the in vivo metabolic defects. The average deficit in leg glucose uptake in NIDDM was 3.11 +/- 0.42 mumol.min-1.100 ml-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587397     DOI: 10.2337/diab.41.6.698

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  32 in total

Review 1.  Metabolic and molecular basis of insulin resistance.

Authors:  Mandeep Bajaj; Ralph A Defronzo
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 4.  Sedentary behaviour is a key determinant of metabolic inflexibility.

Authors:  Corey A Rynders; Stephane Blanc; Nathan DeJong; Daniel H Bessesen; Audrey Bergouignan
Journal:  J Physiol       Date:  2017-07-04       Impact factor: 5.182

5.  Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.

Authors:  D E Kelley; J A Simoneau
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  Heterologously expressed inner lipoyl domain of dihydrolipoyl acetyltransferase inhibits ATP-dependent inactivation of pyruvate dehydrogenase complex. Identification of important amino acid residues.

Authors:  J C Jackson; C C Vinluan; C J Dragland; V Sundararajan; B Yan; J S Gounarides; N R Nirmala; S Topiol; P Ramage; J E Blume; T D Aicher; P A Bell; W R Mann
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.

Authors:  Jose E Galgani; Leonie K Heilbronn; Koichiro Azuma; David E Kelley; Jeanine B Albu; Xavier Pi-Sunyer; Steven R Smith; Eric Ravussin
Journal:  Diabetes       Date:  2008-02-19       Impact factor: 9.461

8.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

Authors:  D E Kelley; M Mokan; J A Simoneau; L J Mandarino
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 9.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

10.  Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes.

Authors:  Hyonson Hwang; Benjamin P Bowen; Natalie Lefort; Charles R Flynn; Elena A De Filippis; Christine Roberts; Christopher C Smoke; Christian Meyer; Kurt Højlund; Zhengping Yi; Lawrence J Mandarino
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.